HepHIV2019 Bucharest Conference: challenges of timely and integrated testing and care
- PMID: 31119111
- PMCID: PMC6446485
- DOI: 10.18683/germs.2019.1151
HepHIV2019 Bucharest Conference: challenges of timely and integrated testing and care
Conflict of interest statement
Conflicts of interest: JR has received honoraria for consulting or speaking at educational events from Abivax, Abbvie, Gilead, Janssen, Merck and ViiV.
Publication types
LinkOut - more resources
Full Text Sources